Nanjing, China., April 09, 2019-IASO Biotherapeutics(IASO Bio), a clinical stage biotechnology company advancing the development of innovative therapies for cancer, today announced that IASO Bio will present clinical results (Abstract#8013) at American Society of Clinical Oncology Annual Meeting 2019 in Chicago Illionis on May 31-June 4.

For more information, please visit: https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.8013